◆ 会议时间:2025年10月16-19日
◆ 会议地点:捷克共和国 布拉格
◆ 会议简介:
2025年第20届欧洲神经肿瘤学会(EANO)年会将2025年10月16-19日在捷克共和国布拉格举行,会议由欧洲神经肿瘤学协会(EANO)主办。
欧洲神经肿瘤学协会(EANO)是代表涉及中枢神经系统(CNS)肿瘤的预防、诊断和治疗的所有医学和科学学科的欧洲多学科神经肿瘤学组织。EANO致力于通过创新的研究和协同的教育与培训促进神经肿瘤学的发展-宣译。EANO加强所有相关学科之间的合作——神经肿瘤学、神经外科、神经病理学、神经放射学、放射肿瘤学以及护理学,旨在弥补中枢神经系统恶性肿瘤管理方面的科学、知识和实践方面的差距。目前EANO在70多个国家拥有600多名成员。EANO与美国神经肿瘤学会(SNO)和亚洲神经肿瘤学会(ASNO)等学会合作,共同促进国家间的合作。EANO、SNO和ASNO是世界神经肿瘤协会联合会(WFNOS)的成员学会。EANO为会员提供多种服务,组织各种科学和教育会议以及高水准的讲座,内容涵盖神经肿瘤学领域的所有学科,其中包括每年一次的EANO会议和每四年一届的WFNOS会议(未经本站许可,禁止复制摘录转载本站任何内容-领域国际医学会议网)。
The 20th Meeting of the European Association of Neuro-Oncology (EANO 2025)
时间/ Date:
October 16-19, 2025
地点/Location:
Prague, Czech Republic
EANO Educational Day: Thursday, October 16, 2025
EANO Meeting: Thursday, October 16 (as of 17:00 CEST) - Sunday, October 19, 2025
摘要征文投稿:
Abstract submission
Abstract Submission will open end of February 2025;
Submission deadline: Wednesday, April 30, 2025 at 23:59 hrs CEST.
此提交摘要>>>Submit Abstract>>>
GENERAL INFORMATION ON ABSTRACT SUBMISSION
- EANO accepts regular, encore or trial in progress abstracts.
- Abstracts containing no results or structure will be rejected.
- Abstracts with the obvious goal of advertising corporate products or services, will be rejected.
- All submitted abstracts will be anonymised and reviewed by an independent review panel coordinated by the Scientific Committee.
- Authors will be notified about the status of their submission and the final assignment (oral presentation or poster) via email by June 25, 2025.
- Accepted abstracts will be published on the website of Neuro-Oncology beginning of October 2025.
- There will not be a printed abstract book.
- The embargo for abstracts submitted to EANO 2025 will lift on October 2, 2025.
To prepare your abstract submission please carefully read all the instructions and information in the sections “Guidelines and Submission Steps” and “Online Submission Portal” below.
CORRECTIONS / WITHDRAWALS OF ABSTRACTS
- Submitted abstracts can be corrected / withdrawn via the online submission portal until the submission deadline of April 30, 2025.
- Corrections or withdrawals after the deadline have to be requested in an email to eano-meetings@eano.eu
- No corrections / withdrawals are possible after July 31, 2025.
REGISTRATION
At least the presenting author of an abstract is obliged to register and pay the congress registration fee within 2 weeks (but not later than July 31, 2025) after notification on acceptance. In the event of non-fulfillment, the abstract will be withdrawn by the organisers.
Guidelines and Submission Steps
Once you have logged into the submission portal with your account, click on the “+New” button to start with your abstract submission.
Read through the affirmations carefully and confirm them.
SUBMISSION STEP 1: TITLE
- In the title, please use capital letters ONLY where necessary (e.g. "Detection of two novel large mutations in SLC7A9 by semi-quantitative fluorescent multiplex PCR").
- Please DO NOT line breaks in the title. Use italics only where required by nomenclature.
- The title is limited to 25 words!
SUBMISSION STEP 2: AFFIRMATION / ALLOCATION / TYPE
1. Confirm the affirmation regarding the registration.
2. Please indicate whether your abstract is a regular, encore or trial in progress abstract. For an encore abstract please fill in where the abstract has been published before (journal name, issue, name of conference…) and provide a rationale for the resubmission.
SUBMISSION STEP 3: TOPIC
Please allocate your submission to a suitable topic from the list provided. Select only ONE topic that best relates to the main subject of your abstract.
01. Tumour cell biology, heterogeneity and plasticity
02. Microenvironment
03. Imaging
04. Computational neuro-oncology
05. Advanced diagnostics and biomarkers
06. Neurocognition and connectome
07. Neurosurgery, drug delivery and advanced techniques
08. Immunotherapy
09. Radiation
10. Pediatric brain tumors
11. Brain metastasis and leptomeningeal disease
12. Adult glioma
13. Meningioma
14. Rare CNS tumors
15. Palliative and supportive care/QoL
16. Public cancer policies and patient involvement
17. Clinical neuro-oncology
18. Preclinical neuro-oncology
SUBMISSION STEP 4: KEYWORDS
- Please enter up to 3 keywords describing your work (at least 1 required).
SUBMISSION STEP 5: AUTHORS
- No more than 35 authors can be listed.
- A maximum of 2 affiliations per author is allowed.
- First you need to add the presenting author information. The contact details will be prepopulated from the profile information you supplied. In case you will not present the abstract at the conference, you can overwrite the information.
- In the next step you can add institutions, add co-authors, change who is presenting (marked in green), change the order of authors or add a consortium.
- To add a new author click on "Add Author" and check if the person is already in the system by entering their email address and clicking on "Search".
- If the person is already in the system, you can select them from the provided list by clicking on "Add". Review the prepopulated contact information, add any missing information and potential conflicts of interest, save and continue.
- If the person is not in the system yet, use the button "Enter your Author here!", add all information, save and continue.
- DISCLOSURE INFORMATION: In order to help readers form their own judgments of potential bias in published abstracts, submitters are asked to declare any competing financial interests of all authors. Contributions of up to EUR 10.000,- (or equivalent value in kind) per year per entity are considered "Modest". Contributions above EUR 10.000,- per year are considered "Significant".
SUBMISSION STEP 6: ABSTRACT TEXT
The abstract body should be structured as follows:
- Background
- Material and Methods
- Results
- Conclusion
Concerning the abstract format and structure please see the SAMPLE ABSTRACT
- The text cannot exceed 2500 characters without spaces (350-400 words), excluding title and authors. Minimum 500 characters.
- The abstract must be submitted in good English.
- No tables, no graphics or illustrations are allowed.
- No literature must be cited.
- The text may be typed in or copy/pasted from an existing document.
- Special characters are widely supported.
- Support/Disclosure: Enter the source(s) of contributed support and/or grant numbers at the end of the abstract text section.
SUBMISSION STEP 7: PRESENTATION PREFERENCE
- During submission, authors can select whether they prefer an oral or poster presentation.
- Please indicate your preference, especially in case you do not want your abstract to be selected for an oral presentation.
SUBMISSION STEP 8: MORE INFORMATION
Please indicate if
- you want to apply for a Travel Scholarship and select the Scholarship you are eligible for. Only applicable for abstract submissions within the regular submission (deadline April 30, 2025);
- you would like to be considered to publish a manuscript related to your abstract in Neuro-Oncology;
- indicate if you are a Nurse/AHP submitting an abstract.
SUBMISSION STEP 9: SUBMISSION SUMMARY
- The summary page will display all information related to your abstract.
- You may save the summary page for your records as a PDF. The system also has an e-mail confirmation feature. Simply click the appropriate link on the summary page and fill in your email address(es) in the appropriate box.
- If you choose to delete the submission, this can be made here. Please note that you will not be able to retrieve deleted submissions.
CORRECTIONS / WITHDRAWALS OF ABSTRACTS
- Titles of submitted abstracts are displayed on your submission site, together with the information on whether the submission is complete or incomplete. To edit one of your abstracts, simply click on the title.
- Submitted abstracts can be corrected / withdrawn via the online submission portal until the submission deadline of April 30, 2025.
- Corrections or withdrawals after the deadline have to be requested in an email to eano-meetings@eano.eu
- No corrections / withdrawals are possible after July 31, 2025.
Dear EANO members, colleagues and friends,
The 20th Meeting of the European Association of Neuro-Oncology (EANO 2025) will be held in Prague (Czech Republic). Its stunning architecture and rich history provide an inspiring backdrop that fosters creativity and collaboration. The city's blend of Gothic cathedrals, Baroque palaces, and modern amenities creates a unique atmosphere that engages attendees both intellectually and aesthetically. Prague’s central location in Europe makes it easily accessible for international participants, enhancing global attendance. The city's vibrant culture, delicious cuisine, and famous hospitality ensure that delegates feel welcomed and energized. Attendees can bond over a leisurely stroll along the Vltava River or enjoy a traditional Czech meal. With its captivating ambiance and world-class facilities, Prague not only facilitates meaningful discussions but also leaves a lasting impression on all who visit.
The annual EANO meeting will kick off with a multiprofessional interdisciplinary Educational Day with separate tracks on Thursday, October 16 and the main scientific programme will commence on Friday, October 17. The congress fosters exchange and collaboration between all stakeholders at all career stages in the field of Neuro-Oncology with students and experts in Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals. It aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours.
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central and peripheral nervous system. The successful 2024 EANO meeting in Glasgow attracted more than 1200 participants from all continents and was very highly rated!
During the congress, speakers from across the globe will present the latest clinical trial outcomes, highlight key innovations in Neuro-Oncology, advances in basic and translational science and will discuss how to advance patient care.
Save the date for Europe's largest neuro-oncology congress that attracts participants from all over the world!
Aleksi Sedo |
& |
Michael Platten |
President EANO Meeting 2025 |
|
EANO President |
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|